The distribution of lung cancer across sectors of society in the United Kingdom: A study using national primary care data

BMC Public Health

Volumn 11, Issue , 2011, Pages

  Iyen Omofoman, Barbara ^a   Hubbard, Richard B ^a   Smith, Chris J P ^a   Sparks, Emily ^b   Bradley, Emma ^b   Bourke, Alison ^c   Tata, Laila J ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b Experian Ltd   (United Kingdom)

^c CSD Medical Research   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; FEMALE; HEALTH SURVEY; HUMAN; INCIDENCE; INFANT; LUNG TUMOR; MALE; MIDDLE AGED; PRESCHOOL CHILD; PRIMARY HEALTH CARE; STATISTICS; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; INFANT; LUNG NEOPLASMS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PRIMARY HEALTH CARE; YOUNG ADULT;

EID: 81055136563     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-11-857     Document Type: Article

References (35)

1. National Lung Cancer Audit 2009, Report for the audit period 2008. The NHS Information Centre for Health and Social Care and RCP
2. Variation in survival of patients with lung cancer in Europe, 1985-1989. Janssen-Heijnen MLG, Gatta G, Forman D, Capocaccia R, Coebergh JWW, Grp EW, European Journal of Cancer 1998 34 14 2191 2196 10.1016/S0959-8049(98)00312-8 10773525 (Pubitemid 29036885)
3. Variation in incidence of breast, lung and cervical cancer and malignant melanoma of skin by socioeconomic group in England. Shack L, Jordan C, Thomson CS, Mak V, Moller H, BMC Cancer 2008 8 271 10.1186/1471-2407-8-271 18822122
4. Socioeconomic differences in lung cancer incidence: a systematic review and meta-analysis. Sidorchuk A, Agardh EE, Aremu O, Hallqvist J, Allebeck P, Moradi T, Cancer Causes & Control 2009 20 4 459 471 10.1007/s10552-009-9300- 8 22084783
5. Equity of colorectal cancer screening: cross-sectional analysis of National Bowel Cancer Screening Program data for South Australia. Ward PR, Javanparast S, Matt MA, Martini A, Tsourtos G, Cole S, Gill T, Aylward P, Baratiny G, Jiwa M, et al. Aust N Z J Public Health 2011 35 1 61 65 10.1111/j.1753-6405.2010.00637.x 21299702
6. Outcome-based equity in the treatment of colon cancer patients in Finland. Hakama M, Karjalainen S, Hakulinen T, Int J Technol Assess Health Care 1989 5 4 619 630 10.1017/S0266462300008497 2634632 (Pubitemid 20153105)
7. Identifying patients with a cancer diagnosis using general practice medical records and Cancer Registry data. Pascoe SW, Neal RD, Heywood PL, Allgar VL, Miles JN, Stefoski-Mikeljevic J, Fam Pract 2008 25 4 215 220 10.1093/fampra/cmn023 18550895
8. Feasibility study and methodology to create a quality-evaluated database of primary care data. Bourke A, Dattani H, Robinson M, Inform Prim Care 2004 12 3 171 177 15606990 (Pubitemid 39534583)
9. Cancer incidence in The Health Improvement Network. Haynes K, Forde KA, Schinnar R, Wong P, Strom BL, Lewis JD, Pharmacoepidem Dr S 2009 18 8 730 736 10.1002/pds.1774
10. Validation of ischemic cerebrovascular diagnoses in the health improvement network (THIN). Ruigomez A, Martin-Merino E, Rodriguez LA, Pharmacoepidemiol Drug Saf 2010 19 6 579 585 10.1002/pds.1919 20131328
11. Validation of THIN data for non-melanoma skin cancer. Meal A, Leonardi-Bee J, Smith C, Hubbard R, Bath-Hextall F, Qual Prim Care 2008 16 1 49 52 18700078 (Pubitemid 351454579)
12. Validity of The Health Improvement Network (THIN) for epidemiologic studies of hepatitis C virus infection. Lo Re V, Haynes K, Forde KA, Localio AR, Schinnar R, Lewis JD, Pharmacoepidemiol Drug Saf 2009 18 9 807 814 10.1002/pds.1784 19551699
13. Mosaic and its uses in research. Mosaic UK, 2007
14. Health and deprivation: Inequality and the North. Townsend P, Phillimore P, Beattie A, New York: Croom Helm 1988
15. The relative power of geodemographics vis a vis person and household level demographic variables as discriminators of consumer behaviour. Webber R, Centre for Advanced Spatial Analysis (UCL) 2004 http://eprints.ucl.ac.uk/202/ (Accessed 29 September 2011)
16. Geodemographic profiling benefits stop-smoking service. de Gruchy J, Robinson J, British Journal of Healthcare Computing and Information Management 2007 24 29 31
17. Social marketing in action-geodemographics, alcoholic liver disease and heavy episodic drinking in Great Britain. Powell J, Tapp A, Sparks E, International Journal of Nonprofit and Voluntary Sector Marketing 2007 12 177 187 10.1002/nvsm.309
18. Insights into social disparities in smoking prevalence using Mosaic, a novel measure of socioeconomic status: an analysis using a large primary care dataset. Sharma A, Lewis S, Szatkowski L, Bmc Public Health 2010 10 755 10.1186/1471-2458-10-755 21138555
19. EPIC, THIN data from EPIC: A guide for researchers London 2009
20. Number of registrations per year and age-standardised incidence rates (ASR) per 100, 000 European standard population, by area of residence; Cancer site C33-C34: Trachea, Bronchus and Lung; Period of diagnosis 2003-2007. UK Cancer Information Service, 2010 [obtained via personal communication, July 2010]
21. On the spatial representation and accuracy of address-based data in the United Kingdom. Gatrell A, Int J Geographic Inform Syst 1989 3 335 348 10.1080/02693798908941520
22. Multimedia guide to mosaic public sector. Experian, 2009
23. Temporal and within practice variability in the health improvement network. Haynes K, Bilker WB, Tenhave TR, Strom BL, Lewis JD, Pharmacoepidemiol Drug Saf 2011 20 9 948 955 21755569
24. STATA, Stata/SE 11.0 Texas: StataCorp LP 11 2009
25. Office for National Statistics (ONS), Survival Rates in England, patients diagnosed 2001-2006 followed up to 2007
26. Quality and Outcomes Framework. National Institute for Health and Clinical Excellence, 2011 http://www.nice.org.uk/aboutnice/qof/qof.jsp Accessed 29 September 2011
27. Lung cancer in England: information from the National Lung Cancer Audit (LUCADA). Rich AL, Tata LJ, Stanley RA, Free CM, Peake MD, Baldwin DR, Hubbard RB, Lung Cancer 2011 72 1 16 22 10.1016/j.lungcan.2010.07.002 20688413
28. Cancer Registration Statistics: Registration of cancers diagnosed in 2008, England. Office for National Statistics, 2010 http://www.ons.gov.uk/ons/ rel/vsob1/cancer-statistics-registrations - england - series-mb1-/no - 39 - 2008/cancer-statistics - registrations-series-mb1.pdf
29. Performance of the QRISK cardiovascular risk prediction algorithm in an independent UK sample of patients from general practice: a validation study. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Brindle P, Heart 2008 94 1 34 39 10.1136/hrt.2007.134890 17916661
30. The importance of defining periods of complete mortality reporting for research using automated data from primary care. Maguire A, Blak BT, Thompson M, Pharmacoepidemiol Drug Saf 2009 18 1 76 83 10.1002/pds.1688 19065600
31. National comparisons of lung cancer survival in England, Norway and Sweden 2001-2004: differences occur early in follow-up. Holmberg L, Sandin F, Bray F, Richards M, Spicer J, Lambe M, Klint A, Peake M, Strand TE, Linklater K, et al. Thorax 2010 65 5 436 441 10.1136/thx.2009.124222 20435867
32. Pathways to the diagnosis of lung cancer in the UK: a cohort study. Barrett J, Hamilton W, BMC Fam Pract 2008 9 31 10.1186/1471-2296-9-31 18485242 (Pubitemid 351749365)
33. The UK General Practice Research Database. Walley T, Mantgani A, Lancet 1997 350 9084 1097 1099 10.1016/S0140-6736(97)04248-7 10213569 (Pubitemid 27437871)
34. The diagnosis and treatment of lung cancer: Methods, evidence and guidance. National Institute for Clinical Excellence, 2005 http://www.nice.org. uk/nicemedia/pdf/cg024fullguideline.pdf
35. Number of registrations per year and age-standardised incidence rates (ASR) per 100, 000 European standard population, by area of residence; Cancer site C33-C34: Trachea, Bronchus and Lung; Period of diagnosis 2003-2007. UK Cancer Information Service, 2010